On October 23, 2007, the U.S., E.U., Canada, and a handful of other countries announced plans to the negotiate the Anti-Counterfeiting Trade Agreement. The behind-the-scenes discussions had apparently been ongoing for several years, leading some countries to believe that a full agreement could be concluded within a year to coincide […]
Post Tagged with: "acta"
The most troubling aspect throughout the development of ACTA has been the opaque nature of the process. Whilst DFAT has stated that a certain level of confidentiality is required for trade negotiations, and while there is ground to enable a certain degree of secrecy where complex issues warrant negotiations in confidence, there is no valid rationale for the level of secrecy that DFAT has maintained for what is essentially a copyright treaty.
The World Intellectual Property Organization has just concluded the Beijing Treaty on Audiovisual Performances. KEI notes that WIPO is now providing webcasts and video on demand of its sessions and diplomatic conferences. Contrast that with the TPP and ACTA, where discussions are shrouded in secrecy. In fact, four U.S. senators […]
The European Parliament’s INTA committee, the lead committee studying the Anti-Counterfeiting Trade Agreement, has voted to reject ACTA. The 19-12 vote against the agreement means that all five EP committees that studied ACTA voted against ratification. I appeared before the INTA committee’s workshop on ACTA earlier this year and submitted […]
To get a sense of how rare these meeting were, this is the only registered meeting John Baird has had on intellectual property since Bill C-11 was introduced and ACTA was signed by Canada. Similarly, since the introduction of Bill C-11, James Moore has only two intellectual property meetings listed – this one with MPA-Canada and one in March 2012 with the Canadian Wireless Telecommunications Association (in fact, Moore had only three meetings on intellectual property in all of 2011. Those meetings were with MPA-Canada, the Canadian Recording Industry Association, and the Canadian Chamber of Commerce). Even the Simon Kennedy meeting was a rarity as he has had multiple meetings with pharmaceutical companies, but only two (MPA-Canada and the Canadian Council of Chief Executives) that appear to have included copyright.
Given how unusual it is for a single lobby group to gain access to two of Canada’s leading cabinet ministers and a senior department official on the same day, it begs the question of how they did it.